Cargando…

Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer

Detalles Bibliográficos
Autores principales:	Kimura, Hideharu, Araya, Tomoyuki, Yoneda, Taro, Shirasaki, Hiroki, Kurokawa, Koji, Sakai, Tamami, Koba, Hayato, Tambo, Yuichi, Nishikawa, Shingo, Sone, Takashi, Kasahara, Kazuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873691/ https://www.ncbi.nlm.nih.gov/pubmed/31753015 http://dx.doi.org/10.1186/s40880-019-0423-3

Ejemplares similares

NOTCH alteration in EGFR-mutated lung adenocarcinoma leads to histological small-cell carcinoma transformation under EGFR-TKI treatment
por: Koba, Hayato, et al.
Publicado: (2021)

A case of EGFR mutation-positive lung adenocarcinoma in which the T790M allele fraction was increased by repeated EGFR-TKI treatment
por: Kimura, Hideharu, et al.
Publicado: (2019)

Severe coronavirus disease 2019 (COVID‐19) pneumonia patients treated successfully with a combination of lopinavir/ritonavir plus favipiravir: Case series
por: Koba, Hayato, et al.
Publicado: (2020)

Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis
por: Koba, Hayato, et al.
Publicado: (2021)

Immunoglobulin G4-related disease preceded by lung involvement: A case report
por: Abo, Miki, et al.
Publicado: (2017)

Internal Pancreatic Fistula with Pleural Effusion Showing Elevated Levels of Amylase That Emerged 29 Years after Abdominal Surgery
por: Yoneda, Taro, et al.
Publicado: (2020)

Suitability of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration versus Paired Transbronchial Biopsy Specimens for Evaluating Programmed Death Ligand-1 Expression in Stage III and IV Lung Cancer: A Comparative Retrospective Study
por: Matsuoka, Hiroki, et al.
Publicado: (2021)

Real-World Evidence of Safety and Efficacy of Carboplatin plus Nanoparticle Albumin-Bound Paclitaxel in Patients with Advanced Non-Small-Cell Lung Cancer and Preexisting Interstitial Lung Disease: A Retrospective Study
por: Araya, Tomoyuki, et al.
Publicado: (2019)

Two cases of chronic obstructive pulmonary disease evaluated by dynamic-ventilatory digital radiography for pulmonary function and assessment of treatment efficacy
por: Ohkura, Noriyuki, et al.
Publicado: (2021)

Antitumor effects of inductive hyperthermia using magnetic ferucarbotran nanoparticles on human lung cancer xenografts in nude mice
por: Araya, Tomoyuki, et al.
Publicado: (2013)

Late-onset programmed cell death protein-1 inhibitor-induced pneumonitis after cessation of nivolumab or pembrolizumab in patients with advanced non-small cell lung cancer: a case series
por: Kimura, Hideharu, et al.
Publicado: (2021)

Case report: Migraine that persisted for over 20 years disappears after treatment for pulmonary arteriovenous fistula
por: Kakeshita, Kazuyuki, et al.
Publicado: (2020)

Successful Treatment of Advanced Thymic Carcinoma with Carboplatin plus nab−Paclitaxel and Maintenance Monotherapy with nab−Paclitaxel: Two Case Reports
por: Araya, Tomoyuki, et al.
Publicado: (2020)

A case of gingival cancer with pulmonary metastases that developed complete atrioventricular block and ventricular fibrillation as a result of myocardial metastases
por: Yoneda, Taro, et al.
Publicado: (2016)

Every reason to discontinue lithium
por: Salgado, Manuel E Fuentes, et al.
Publicado: (2014)

Transition of the PD-1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re-challenge
por: Nose, Taku, et al.
Publicado: (2022)

PM381. Reason for clozapine discontinuation
por: Cho, Jin-Woo, et al.
Publicado: (2016)

Interstitial pneumonitis after COVID-19 vaccination: A report of three cases
por: Shimizu, Takahiro, et al.
Publicado: (2022)

Efficacy and Safety of Nivolumab in Patients with Advanced Non-small-cell Lung Cancer and Poor Performance Status
por: Katsura, Hideyuki, et al.
Publicado: (2019)

Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
por: Chapman, Paul B, et al.
Publicado: (2021)

Prognostic Markers in Head and Neck Cancer Patients Treated with Nivolumab
por: Nishikawa, Daisuke, et al.
Publicado: (2018)

Reasons given by mothers for discontinuing breastfeeding in Iran
por: Olang, Beheshteh, et al.
Publicado: (2012)

Reasons for discontinuation of radiation therapy and effective countermeasures
por: Maebayashi, Toshiya, et al.
Publicado: (2018)

Unusual Aorto-mitral Discontinuity Caused by Infective Endocarditis
por: Nakagawa, Tamami, et al.
Publicado: (2019)

P060: Prognosis of patients with relapsed and refractory classic Hodgkin lymphoma after nivolumab discontinuation and efficacy of nivolumab retreatment
por: Fedorova, Liudmila, et al.
Publicado: (2022)

Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation
por: Takahashi, Wakana, et al.
Publicado: (2021)

Possible abscopal effect after discontinuation of nivolumab in metastatic renal cell carcinoma
por: Nakajima, Nobuyuki, et al.
Publicado: (2020)

A Durable Response after the Discontinuation of Nivolumab in an Advanced Gastric Cancer Patient
por: Yatsuda, Yukino, et al.
Publicado: (2020)

Eosinophil prognostic scores for patients with head and neck squamous cell carcinoma treated with nivolumab
por: Nishikawa, Daisuke, et al.
Publicado: (2020)

Two cases of delayed onset of immune‐related adverse events after discontinuation of nivolumab in patients with metastatic renal cell cancer
por: Nakai, Yasutomo, et al.
Publicado: (2021)

Surgery and Reason: The End of History and the Last Surgeon
por: Magouliotis, Dimitrios E., et al.
Publicado: (2023)

Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation in fertility treatment
por: Gameiro, S., et al.
Publicado: (2012)

Re: Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab
por: Pampín-Sánchez, R, et al.
Publicado: (2021)

Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab
por: Boku, Narikazu, et al.
Publicado: (2021)

Lung Adenocarcinoma with Lynch Syndrome and the Response to Nivolumab
por: Kawashima, Yosuke, et al.
Publicado: (2019)

Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation
por: Matza, Louis S, et al.
Publicado: (2012)

Reasons for discontinuing clozapine: A cohort study of patients commencing treatment
por: Legge, Sophie E., et al.
Publicado: (2016)

Adherence to and persistence with zoledronic acid treatment for osteoporosis—reasons for early discontinuation
por: Spångeus, Anna, et al.
Publicado: (2020)

Duration of natalizumab therapy and reasons for discontinuation in a multiple sclerosis population
por: Conway, Devon S, et al.
Publicado: (2020)

General characteristics and reasons for the discontinuation of drug clinical trials in mainland China
por: Huo, Ben-nian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jcim3dqf8gcl93pn3apmg2kl1a